These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24809861)

  • 21. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
    Lunha K; Thet KT; Ngudsuntia A; Charoensri N; Lulitanond A; Tavichakorntrakool R; Wonglakorn L; Faksri K; Chanawong A
    Infect Genet Evol; 2020 Nov; 85():104577. PubMed ID: 33007498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.
    Livermore DM; Hill RL; Thomson H; Charlett A; Turton JF; Pike R; Patel BC; Manuel R; Gillespie S; Balakrishnan I; Barrett SP; Cumberland N; Twagira M;
    Int J Antimicrob Agents; 2010 Jan; 35(1):19-24. PubMed ID: 19910162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
    Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
    El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.
    Park YK; Choi JY; Shin D; Ko KS
    Int J Antimicrob Agents; 2011 Jun; 37(6):525-30. PubMed ID: 21497062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran.
    Sepahvand S; Doudi M; Davarpanah MA; Bahador A; Ahmadi M
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1401-6. PubMed ID: 27592491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.
    Rolain JM; Diene SM; Kempf M; Gimenez G; Robert C; Raoult D
    Antimicrob Agents Chemother; 2013 Jan; 57(1):592-6. PubMed ID: 23070160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emission of extensively-drug-resistant Acinetobacter baumannii from hospital settings to the natural environment.
    Seruga Music M; Hrenovic J; Goic-Barisic I; Hunjak B; Skoric D; Ivankovic T
    J Hosp Infect; 2017 Aug; 96(4):323-327. PubMed ID: 28532975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
    Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii.
    Lim TP; Ong RT; Hon PY; Hawkey J; Holt KE; Koh TH; Leong ML; Teo JQ; Tan TY; Ng MM; Hsu LY
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7899-902. PubMed ID: 26438500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y; Chai D; Wang R; Liang B; Bai N
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
    Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy.
    Zarrilli R; Di Popolo A; Bagattini M; Giannouli M; Martino D; Barchitta M; Quattrocchi A; Iula VD; de Luca C; Scarcella A; Triassi M; Agodi A
    J Hosp Infect; 2012 Dec; 82(4):260-5. PubMed ID: 23102814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.